In previous study, we found that the chemokine receptor 9 (CCR9) was highly expressed on CD4 + T cells from patients with T-cell lineage acute lymphocytic leukemia (T-ALL) and mediated leukemia cell infiltration and metastasis. Combined use of interleukin 2 (IL-2) and IL-4 promoted the internalization of CCR9 and therefore attenuated leukemia cell infiltration and metastasis. In this study, we preliminarily investigated the mechanism of internalization of CCR9 on MOLT4 cell model (a human leukemia T-cell line, naturally expresses CCR9) and found that IL-2 upregulated the cell surface expression of IL-4R(CD124) greatly, whereas IL-4 had no significant influence on (CD25) and subunits (CD122) of IL-2R. Moreover, specific inhibitors, such as staurosporine, H89 and heparin, inhibited internalization of CCR9, which indicated a role of protein kinase C (PKC) and G protein-coupled kinase 2 (GRK2), respectively. Furthermore, GRK2 was upregulated and translocated to cell membrane in IL-2 and IL-4 treated cells which indicated that PKC could be a prerequisite for GRK2 activity.
Introduction
Receptor internalization is an important physiological "feed back" pathway that prevents the overreaction of cells to outside stimulants. There are three different internalization mechanisms: 1) The agonist-dependent internalization belongs to homologous desensitization. 2) The agonist-independent internalization involves in heterologous desensitization. 3) Tonic internalization. However, in each mechanism, receptor phosphorylation is an important step. It has been demonstrated that phosphorylated receptor uncouples from G protein and binds to -arrestins (1, 2) and subsequently sequesters into the intracellular membrane compartments. G protein-coupled receptor kinases (GRKs) and secondmessenger-dependent kinases (mainly PKC and PKA) are the primary kinases to mediate receptor phosphorylation. The internalized receptors will either be degraded or restored to cell membrane depending on the intracellular compartment in which it travels to, i.e., lysosome or endosome (3, 4) .
Chemokine receptor 9 (CCR9) is a member of G protein-coupled receptor (GPCR) and plays an important role in T-cell development and tissue-specific homing after binding with its specific ligand, CCL25. Moreover, CCR9 was also detected in some carcinoma cells and mediates their organ-selective metastasis and perhaps their longer survival. For example, the prostate cancer cell lines PC3 and LNCaP were found to express CCR9, while the LNCaP cells with higher CCR9 expression were more invasive than PC3 cells after CCL25 induction (5) . Besides, in adult T-cell leukemia (ATL), the expression of CCR9 is inducible and may be involved in infiltration and/or localization of ATL cells in the gastrointestinal tract (6) .
IL-2 and IL-4 are important cytokines and mediate complex signal transduction when binding to their receptors. Their receptors are constitutively expressed on various carcinomas. IL-2R is a multichain receptor complex consisting of -, -, and a common -chain (c), shared by other cytokine receptors including IL-4R, IL-7R, IL-9R, and IL-15R (7) . The high affinity of IL-2 receptor is composed of all the three subunits, while- heterodimer and - heterodimer show intermediate and low binding affinity for IL-2 (8) . The IL-4R complex includes three different types of receptors. Type I IL-4R composed of IL-4R and IL-2Rc; type II composed of IL-4R and IL-13R1 chains; type III expresses all the three chains (9, 10) .
In previous study, we found that CCR9 was highly expressed on T-cell lineage acute lymphocytic leukemia (T-ALL) CD4 + T cells; its ligand CCL25 strengthened cell chemotaxis and adhesion (11) . T-ALL is notorious for its infiltration into various organs, such as the lymph nodes, liver, spleen, lungs, skin, intestinal tract, and even brain and the process is partialy induced by chemokines and its receptors (12) . Hence, the loss of the chemokine receptor will contribute in the control and cure of disease and may become an implicated treatment. In previous experiments, we found that IL-2 and IL-4, together, at low concentration (10 ng/ml), significantly induced internalization of CCR9 in CD4 + T cells from T-ALL without affecting their mRNA and protein expression, and subsequently down-regulated its functions including chemotaxis and adhesion. The primary goal of the present study was to elucidate the interaction between IL-2 and IL-4 and also to figure out the right protein kinases responsible for the agonist-independent internalization triggered by IL-2 and IL-4.
Materials and Methods

Chemicals, antibodies and cell line
Recombinant human IL-2 and IL-4 were purchased from PeproTeck Inc. Anti-CCL25 monoclonal antibody (mAb) was purchased from Peprotech, FITC-labeled CD124 mAb was obtained from eBioscience Inc., PE-conjugated anti-CD25 mAb was obtained from BioLegend, FITC-labeled anti-CD122 mAb and FITC-labeled anti-CCR9 mAb were purchased from R&D, GRK2 mAb was obtained from CST, H89 and staurosporine were obtained from Calbiochem, and PMA was purchased from Sigma. MOLT4 cell line was purchased from American Type Culture Collection.
Flow cytometric analysis
For the detection of CCR9, cells were pretreated with or without IL-2 and/or IL-4 at different concentrations. After blocking with 2% BSA for 15 min, the cells were stained with FITC-labeled anti-CCR9 mAb (1 g/10 5 cells) for 45 min at 4°C. Then the cells were washed twice with PBS and finally resuspended in 400 l PBS for analysis using flow cytometer (Beckman, USA). To assay internalization, the relative CCR9 surface expression (%) was calculated as: 100 
Immunofluorescence digital confocal microscopy detection
For the detection of internalization, cells were cultured with poly L-lysine coated coverslips for 10 min, and then fixed with 4% paraformaldehyde for 10 min at room temperature. Then cell membranes were permeabilized with a solution of 1% Triton X-100 in PBS for 15 min and coverslips were blocked with a solution of 2% BSA in PBS for 20 min to reduce non-specific binding. FITC-labeled anti-CCR9 mAb was diluted into 25 g/ml and added to the coverslips. The cells were incubated overnight at 4°C, and then washed twice with PBS before detection. The analyses were performed on confocal microscope (Leica, Germany).
RT-PCR amplification
Poly (A)+ RNA was isolated from cultured MOLT4 cells using the TRI Reagent LS (Molecular Research Center, Inc.), and was reverse transcribed and amplified with RNA PCR Kit (TaKaRa Biotechnology Co., Ltd.). The RT-PCR primers used to amplify GRKs (the PCR retain conditions were listed in Table 1 ). PCR products were separated on 1.5% agarose gels, and the gel imaging system (Vilber Lourma, France) was used to scan the gel and quantify the level of mRNA. GAPDH in the samples was co-amplified as an internal control.
Total and membrane protein isolation and Western blot quantitation
Total protein extraction protocol was based on Sambrook et al. (13) . Cells were washed with PBS and suspended in a lysis buffer (20 mM Na 2 HPO 4 pH 7.4, 150 mM NaCl, 1% Triton X-100, 1% aprotinin, 1 mM phenylmethylsulfonyl fluoride, 10 g/L leupeptin, 100 mM NaF, and 2 mM Na 3 VO 4 ). After 30 min of shaking at 4°C, the mixture was centrifuged (12,000 g) for 5 min, and the supernatant was collected. Protein concentrations were measured according to Bradford method. The translocation of GRK2 from cytosol to membrane was detected through membrane isolation of MOLT4 cells. Briefly, MOLT4 cells pellets were homogenized in 500 l of 25 mM Tris-HCl, containing 4 mM EGTA, 2 mM EDTA, 5 mM dithiothreitol, 1 mM PMSF, 1 mg/ml pepstatin, 1 mg/ml leupeptin, 1 mg/ml aprotinin, and 1 mM benzamidine, at pH 7.5 (buffer A). After 30 min incubation at 4°C, cells were homogenized by 20 strokes with a 1 ml homogenizer. After centrifugation at 100,000 g for 1 h at 4°C, the supernatant (representing the cytosolic fraction) was collected, and the pellet was resuspended in 150 l buffer A supplemented with 1% Triton X-100. After incubation for 1 h at 4°C, the suspension was centrifuged at 100,000 g for 1 h at 4°C. This second supernatant (particulate fraction) was containing the membrane-associated GRK2. The distribution of -tubulin was used to estimate the purity of particulate fractions.
Sixty g of total protein was separated by 8% sodium dodecylsulfate-polyacrylamide gel electrophoresis and was transfered onto nitrocellulose sheets. After blocking with 5% non-fat dry milk solution containing 10 mM Tris (pH 7.5), 150 mM NaCl, and 0.05% Tween-20, the membranes were incubated overnight at 4°C with GRK2 (1:1,000), -actin (1:1,000) or -tubulin mAb respectively. The secondary antibody was HRP-conjugated goat-anti-rabbit antibody (1:1,000) or goat-anti-mouse antibody (1:1,000), respectively. Signals were detected using an enhanced chemiluminescence Western blotting detection kit. Semi-quantification was performed using the Quantity One densitometry analysis software (Bio-Rad).
Results
IL-2 and IL-4 induce CCR9 internalization on MOLT4 cells
Receptor internalization contributes to the functional desensitization of receptors. In previous study, we found that CCR9 expression correlated with the enhanced migration and invasion of T-ALL cells when induced by the ligand of CCR9, CCL25. IL-2 and IL-4 together can induce significantly internalization of CCR9 on T-ALL CD4 + cells (9) and subsequently neutralize their chemotactic migration and adhesion. In order to clarify the internalization mechanisms, we continued the study on MOLT4 cells, a T-ALL cell line that naturally expresses CCR9 (14, 15) . Cell surface CCR9 was quantified by FACS analysis and its presenting percents were calculated by MFI which described in "Materials and Methods". After treatment with both IL-2 (10 ng/ml) and IL-4 (10 ng/ml) overnight (12 h), cell surface CCR9 decreased obviously and only 20% expressed CCR9 ( Figure  1A ). However, neither of the two cytokines alone had significant influence on CCR9 expression. The percentages of CCR9 + cells sustained at 84% (IL-2 treated) and 76% (IL-4 treated) respectively compared to the untreated group ( Figure 1A ).
The confocal microscopy detection directly demonstrated the changed distribution of CCR9. As expected, the majority of the CCR9 staining was on the cell surface and evenly distributed in untreated cells. After cytokine treatment, only the combination culture of IL-2 and IL-4 induced the CCR9 shifting from cell membrane to cytoplasm ( Figure 1B) . The results clearly indicated the synergetic functions of IL-2 and IL-4, and inspired us to further study the mechanisms.
To exclude the possibility that the release of CCL25 during cytokine stimulation could down-regulate CCR9 on MOLT4 cells, we tested whether the reduction of CCR9 could be abolished by anti-CCL25 mAb neutralization (50 g/ml). As a result, the coculture of anti-CCL25 mAb with IL-2 and IL-4 had no influence on CCR9 internalization, suggesting that IL-2 and IL-4 directly act on MOLT4 cells to down-regulate CCR9.
IL-4 receptor is responsible for the CCR9 internalization
For IL-2R, CD25 and CD122 were the specific binding subunits for IL-2, while the CD132 (c) chain interacted weakly (16) . For IL-4R, CD124 bind to IL-4 specifically with high affinity, and other components (c chain and IL-13 R1) only play roles in signal transduction. In order to clarify the interaction between IL-2 and IL-4 on MOLT4 cells, we detected the expressions CD25, CD122 and CD124 on the cells treated with IL-4 or IL-2, respectively. CD25 and CD122 were absent and weakly presented on MOLT4 cell surface (17) , which is consistent with our results (Figure 2 ). The percentage of CD25 + or CD122 + cells was about 9.5% or 48.6%, and the MFI was 7.38 and 12.62 compared to 2.30 and 2.94 for their isotype controls. Moreover, the IL-4 (10 ng/ml) treatment for 12 h had no obvious influence on the expressions of these two CD molecules except inducing a slight MFI reduction of CD122 from 12.62 to 11.62 ( Figure  2A ). Even when we increased the concentration of IL-4 (from 10 ng/ml to 40 ng/ml), the percentage of double positive cells was retained at low levels ( Figure 2B ). This indicated that IL-4 didn't affect the expression of the two important subunits of IL-2R, and their low expression suggested the absence or weakly presence of high affinity IL-2R on MOLT4 cells. Moreover, IL-4 shares the c chain with IL-2, the relative inhibition may exist because of their competitive binding.
On the other hand, the expression of CD124 on cell surface obviously changed after exposure to IL-2 ( Figure 3) . The MFI, indicating the receptor density on cell surface, increased from 5.45 to 13.73 following IL-2 (10 ng/ml, 12 h) treatment, demonstrating high upregulation of CD124. Moreover, the effect was concentration-dependent to some extent, as the MFI was up to 20.83 under 20 ng/ml IL-2 treatment and the maximal responsiveness (MFI 26.64) to IL-2 was seen at 30 ng/ml, while the effect decreased (MFI 22.63) at 40 ng/ml. As the primary ligand-binding subunit of IL-4R, CD124 shows high affinity to IL-4 and its increase might augment the reaction of cells to low concentration of IL-4.
Involvement of PKC and GRK2 in IL-2 + IL-4 induced CCR9 internalization
Various protein kinases play important roles in receptor phosphorylation which contributes to their subsequent sequestration from cell membrane. To detect their functions in CCR9 desensitization, cells were pretreated with protein kinase inhibitors before IL-2 and IL-4 treatment. As a result, 15.43% receptors left on cell surface after IL-2 and IL-4 treatment. The special inhibitor of PKA, H89 (3 M, 30 min), couldn't abolish the internalization of CCR9 triggered by IL-2 and IL-4 treatment, as only 22.90% CCR9 remained. In contrast, with the pretreatment of heparin (1 M, 30 min), the inhibitor of pan-GRKs, and staurosporine (0.5 M, 30 min), the specific inhibitor of PKC, CCR9 inhibition was lost significantly and the CCR9 percentages increased to 41.19% and 77.29%, respectively (Figure 4) . The results suggested that PKC and GRKs were involved in CCR9 internalization triggered by IL-2 and IL-4, and obviously, PKC had greater contribution than GRKs.
To further demonstrate the PKC involvement in CCR9 internalization, PMA, a potent PKC activator, was used to determine if pharmacological activation of PKC would be able to cause CCR9 down-regulation. As shown in Figure 5A , treatment of MOLT4 with PMA (1 M, 3 h) resulted in a significant down-modulation of CCR9 surface expression, as the surface receptors decreased to 50.8%. The confocal microscopy detection demonstrated the changed distribution of CCR9 from cellular membrane to cytosol ( Figure 5B ). Based on those results, we could conclude that both PKC and GRKs mediated the sequestration, and internalization, and could be an intracellular traffic agent of CCR9 on MOLT4 cells.
Detection of mRNA and protein level of GRKs
Having found that CCR9 internalization was partly driven by the activation of GRKs, we then quantified the mRNA level of this family. As we know, the GRK family consists of seven members, named GRK1~7. Expression of GRK1 and GRK7 are confined to retinal rods and cones, respectively, whereas GRK4 has very limited expression in the cerebellum, testis and kidney. However, GRK2, GRK3, GRK5 and GRK6 are widely expressed in mammalian tissues (18) . Thus in our experiments, we detected the mRNA level of GRK2, GRK3, GRK5 and GRK6 in MOLT4 cells with or without IL-2 or/and IL-4 treatment. The basal mRNA level of GRK3 was greatly less abundant than other GRK members ( Figure 6A ), which is consistent with previous reports showed that GRK3 is expressed weakly in most mammalian tissues (19) .
After treatment with IL-2 (10 ng/ml) or/and IL-4 (10 ng/ml) for 12 h, the results from RT-PCR assays ( Figure 6A ) and normalized GRK members mRNA levels based on the expressions of housekeeping gene GAPDH ( Figure 6B) showed that GRK6 mRNA decreased obviously only after the exposure to IL-2 + IL-4, and the mRNA levels of GRK3 and GRK5 had no obvious change. Meanwhile, GRK2 mRNA expression was increased after IL-4 or IL-2 + IL-4 treatment. The detection of GRK2 protein level was consistent with its mRNA level. IL-2 and IL-4 together increased GRK2 protein obviously and so did IL-4 alone, but to less extent effective than the former ( Figure 7) . As GRK2 usually located in the cytoplasm and was recruited to cell membrane after its activation, the quantitation of membrane associated GRK2 was performed. The results demonstrated increase abundance of GRK2 in membrane after IL-2 and IL-4 treatment, and PKC inhibitors (staurosporine) attenuated its membrane location as well as the total GRK2 protein. It might indicate the potential up-regulation of GRK2 expression and its translocation by PKC. Interestingly, IL-4 alone couldn't promote the membrane translocation of GRK2, however it slightly upregulated total GRK2 level. As a conclusion, IL-2 and IL-4 together can induce GRK2 expression and activation, while the effect may be mediated by PKC.
Discussion
In this study, both flow cytometry and confocal microscopy analyses demonstrated the CCR9 internalization mediated by IL-2 and IL-4 on MOLT4 cells. Many cytokines have been identified to regulate the expression and function of chemokine receptors on gene or protein levels. IL-3 has been reported to down-regulate the CCR3 surface expression due to diminishing its mRNA expression in human eosinophils (20) . Granulocyte colony-stimulating factor was shown to induce the activation of the CCR2 gene in various myeloid cell lines (21) . Only few reports exist about the internalization of chamokine receptor induced by cytokines, such as TNF- and IFN- can mediate the internalization of CXCR4 from cell surface and the effect is reversible after cytokine removal (22) . But the internalization mechanism has been the object of limited attention. Our study focused on the mechanism of CCR9 internalization triggered by combined IL-2 and IL-4. Previous works reported that IL-4 inhibited the IL-2-triggered STAT5 activity but it also significantly augmented the proliferation of human T cells triggered by IL-2, which demonstrates the different regulation of IL-4 on IL-2 signal transduction (23) . Besides the crosslink of their signal transduction, the mutual regulation of their receptors on cell surface may also contribute to their synergetic effect. IL-4 has been reported to inhibit the expression of IL-2R and  (24), but there are also controversial discoveries declaring that IL-4 can upregulate the expression of IL-2R and IL-2R and potentiate the activated T cell apoptosis triggered by IL-2 (25) . In our experiments, CD25 and CD122 on cell surface were not significantly influenced by IL-4 treatment even at high concentration (40 ng/ml). It is thus clear that the activating or inhibiting effect of IL-4 on IL-2R has cellular specificity. Moreover, IL-4 also had no effect on altering the percent of CD25 + CD122 + cells, suggesting that the high affinity IL-2R was constantly scarce on MOLT4 cells during the whole internalization process. Thus, the physiological effects of IL-2 are limited and may not internalize CCR9 directly. On the other hand, we studied the impact of IL-2 on IL-4R, since it received less attention before. Surprisingly, IL-2 promoted a concentrationdependent increase of CD124 density on cell surface and the change might greatly raise the receptor affinity to ensure the sensitive reaction to low concentration of IL-4.
To date, GPCR internalization is characterized by the receptor phosphorylation by GRKs and/or second messengerdependent kinases, -arrestin binding, and subsequent receptor sequestration (26) . In our experiments, inhibition and activation of PKC could prevent or promote the CCR9 internalization triggered by IL-2 and IL-4, which confirmed the participation of PKC in the process. It is thought that the members of PKC family are the upstream signal molecules in pleiotropic effects of many cytokines on their target cells. For example, the expression of PKC, PKCδ and PKC can be increased by IL-2 on NK cells and subsequently mediate their proliferation or cytotoxic activity (27) . Another study found that IL-2 upregulated PKC activity and inhibited PKC activity (28) . Moreover, IL-4 can induce the translocation of PKC and ζ from the cytosol to the membrane fraction in a human B cell line (29) . Because of the activation of different PKC subtypes by IL-2 and IL-4, we can hypothesize that the internalization of CCR9 might depend on one or more PKC members. As IL-2 can significantly promote the IL-4R expression, which upregulates the IL-4R affinity to IL-4, it may strengthen the activity of specific PKC subtypes under IL-4 stimulation, and the subtypes may involve in IL-4 signaling but not IL-2.
In general, GRKs and -arrestins have been implicated in agonist-dependent, homologous desensitization of GPCRs, whereas second messenger-dependent kinases have been associated with agonist-independent, heterologous desensitization (30) . But there are also exceptions, such as granulocyte-macrophage colony-stimulating factor increased the abundance of GRK3 and might contribute to the sequestration of CXCR4 in human primary monocytederived macrophages (31) . The similar result was found in our experiments, as pan-GRK inhibitor (heparin) also prevented the CCR9 internalization triggered by IL-2 and IL-4 together. In further mRNA and protein level detection of GRKs we found that GRK2 increased following IL-2 and IL-4 treatment and so did its membrane associated abundance. Obviously, the combining treatment of IL-2 and IL-4 promoted GRK2 expression and activity, but it needs further study to prove whether GRK2 can phosphorylate CCR9 directly and subsequently induce its membrane sequestration.
In our following detection, a PKC inhibitor, staurosporine, effectively abrogated the increase of GRK2 expression and membrane translocation in compared to IL-2 and IL-4 treated group. It indicated that GRK2 may act as a down-stream kinase of PKC and may be the direct kinase to phosphorylate the intracellular domain of CCR9. The relationship between PKC and GRK2 has been proved before in many cellular systems. For instance, PKC inhibitors can abolish the H 2 O 2 -induced increase in membranous GRK2. On the contrary, GRK2 has been reported to bind with PKC and down-regulated PKC activity in Jurkat T lymphocyte (32) .
In conclusion, our experiments suggest that the IL-4R upregulated by IL-2 may raise the cell sensitivity to IL-4. Meanwhile, IL-4 has no obvious influence on cellular IL-2 sensitivity because of its uselessness on IL-2R and subunits. Also the results indicate the participation of specific protein kinases (PKC and GRK2) in receptor internalization, whereas PKC activation may be a prerequisite for GRK2. A number of detailed studies should be performed in the future to determine the useful subtype members of PKC and the causal relationship among those elements.
